Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950123-98-003008
Filing Date
1998-03-27
Accepted
1998-03-27 00:00:00
Documents
12
Period of Report
1997-12-28
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 JOHNSON & JOHNSON 10-K405 48083
2 BY-LAWS OF THE COMPANY, AS AMENDED 10/20/97 EX-3.B 33342
3 1995 STOCK OPTION PLAN EX-10.B 12852
4 1991 STOCK OPTION PLAN EX-10.C 11349
5 1986 STOCK OPTION PLAN EX-10.D 13278
6 EXECUTIVE INCOME DEFERRAL PLAN EX-10.I 19953
7 CALCULATION OF EARNINGS PER SHARE EX-11 3825
8 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS EX-12 3209
9 PAGES 26-45 OF THE COMPANY'S ANNUAL REPORT EX-13 138359
10 SUBSIDIARIES EX-21 15766
11 FINANCIAL DATA SCHEDULE EX-27 2000
12 CAUTIONARY STATEMENT EX-99.B 3705
  Complete submission text file 0000950123-98-003008.txt   308186
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 9085240400
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 001-03215 | Film No.: 98575875
SIC: 2834 Pharmaceutical Preparations